Nurix Therapeutics, Inc. (NASDAQ:NRIX) is a favorite amongst institutional investors who own 66%

Ownership research and analyst forecasts help investors understand stock opportunities. Nurix Therapeutics has institutions as top shareholders, indicating confidence in its future. Insider ownership and analyst sentiments also play a role in gauging stock potential.